| Institution: | 1. Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, Brisbane, Australia;2. Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia;3. Experimental Dermatology group, Diamantina Institute, University of Queensland, Brisbane, Australia;4. Faculty of Medicine, The University of Queensland, Brisbane, Australia;5. Leeds Institute of Medical Research at St James’s, Leeds Institute for Data Analytics, School of Medicine, University of Leeds, Leeds, United Kingdom;6. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;7. Melanoma Institute Australia, The University of Sydney, Sydney, Australia;8. Faculty of Medicine and Health, The University of Sydney, Sydney, Australia;9. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and New South Wales (NSW) Health Pathology, Sydney, Australia;10. Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia;11. Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia;12. Cancer Research UK, Manchester Institute, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom;13. Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom;14. Department of Melanoma, Mater Hospital, North Sydney, Australia;15. Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia;16. 23andMe Research Team, 23andMe Inc., Sunnyvale, California, USA;17. Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia;18. Department of Medical Oncology, Mater Hospital, North Sydney, Australia;19. Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia;20. Queensland University of Technology (QUT), Brisbane, Australia |
